Merck & Co., Inc. ( MRK) - Key Metrics
MRK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.59 | $1.19 | ? | ? |
| 2025Q3 | $6.92 | $2.32 | $3.13 | $2.74 |
| 2025Q2 | $6.31 | $1.77 | $1.32 | $1.01 |
| 2025Q1 | $6.17 | $2.02 | $0.99 | $0.47 |
MRK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 71.43% | 22.11 |
| 2025Q3 | 35.11% | 9.06 |
| 2025Q2 | 46.92% | 11.19 |
| 2025Q1 | 40.36% | 11.12 |
MRK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.98% | ? |
| 2025Q4 | 0.70% | 0.81% |
| 2025Q3 | 3.26% | 0.97% |
| 2025Q2 | 1.27% | 1.05% |
| 2025Q1 | 0.52% | 0.91% |
MRK
List: Contenders
Price: $125.20
Dividend Yield: 2.65%
Forward Dividend Yield: 2.72%
Payout Ratio: 57.04%
Dividend Per Share: 3.40 USD
Earnings Per Share: 3.55 USD
P/E Ratio: 31.99
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 7.8 million
Ebitda: 2.3 billionMarket Capitalization: 313.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 65
DGR3: 5.57%
DGR5: 7.12%
DGR10: 6.54%
DGR20: 4.11%